PCTY · Insider Trading
Paylocity Holding Corporation Common Stock
Every open-market purchase and sale reported by PCTY officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-11-03 | Steven I Sarowitz | Director | Sell | −6,374 | −$1.09M |
| 2026-10-29 | Steven I Sarowitz | Director | Sell | −100 | −$17.02K |
| 2026-10-28 | Steven I Sarowitz | Director | Sell | −8,900 | −$1.52M |
| 2026-10-27 | Steven I Sarowitz | Director | Sell | −13,700 | −$2.41M |
| 2026-10-26 | Steven I Sarowitz | Director | Sell | −20,926 | −$3.70M |
| 2026-10-23 | Steven I Sarowitz | Director | Sell | −5,744 | −$978.11K |
| 2026-10-22 | Steven I Sarowitz | Director | Sell | −10,617 | −$1.80M |
| 2026-10-21 | Steven I Sarowitz | Director | Sell | −10,445 | −$1.74M |
| 2026-10-19 | Steven I Sarowitz | Director | Sell | −5,500 | −$913.28K |
| 2026-10-16 | Steven R Beauchamp | Executive Chairman | Sell | −15,000 | −$2.48M |
| 2026-10-16 | Steven I Sarowitz | Director | Sell | −17,694 | −$2.93M |
| 2026-10-02 | Melissa Ann King | SVP Product and Technology | F | −489 | −$69.72K |
| 2026-09-16 | Steven R Beauchamp | Executive Chairman | Sell | −15,000 | −$2.21M |
| 2026-09-09 | Andrew Cappotelli | Sr Vice President Operations | Sell | −69 | −$10.51K |
| 2026-09-02 | Andrew Cappotelli | Sr Vice President Operations | F | −58 | −$9.29K |
| 2026-09-01 | Steven I Sarowitz | Director | Sell | −5,100 | −$808.63K |
| 2026-08-31 | Kenneth B. Robinson | Director | Sell | −800 | −$126.73K |
| 2026-08-31 | Craig Conway | Director | Sell | −3,145 | −$493.14K |
| 2026-08-31 | Steven I Sarowitz | Director | Sell | −19,459 | −$3.07M |
| 2026-08-26 | Steven I Sarowitz | Director | Sell | −441 | −$68.36K |
| 2026-08-21 | Steven I Sarowitz | Director | Sell | −6,660 | −$1.02M |
| 2026-08-20 | Steven I Sarowitz | Director | Sell | −8,539 | −$1.28M |
| 2026-08-20 | Andres Reiner | Director | A | +2,207 | — |
| 2026-08-20 | Ryan Glenn | Chief Financial Officer | Sell | −3,345 | −$500.91K |
| 2026-08-20 | Nicholas Rost | VP CAO & Treasurer | Sell | −520 | −$76.98K |
| 2026-08-20 | Joshua Scutt | SVP Chief Revenue Officer | Sell | −4,730 | −$708.64K |
| 2026-08-20 | Andrew Cappotelli | Sr Vice President Operations | Sell | −2,550 | −$382.06K |
| 2026-08-19 | Toby J. Williams | President and CEO | F | −20,462 | −$3.03M |
| 2026-08-19 | Joshua Scutt | SVP Chief Revenue Officer | F | −3,780 | −$560.50K |
| 2026-08-19 | Andrew Cappotelli | Sr Vice President Operations | F | −2,063 | −$305.90K |
| 2026-08-19 | Ryan Glenn | Chief Financial Officer | F | −6,007 | −$890.72K |
| 2026-08-19 | Nicholas Rost | VP CAO & Treasurer | F | −314 | −$46.56K |
| 2026-08-19 | Steven R Beauchamp | Executive Chairman | F | −4,088 | −$606.17K |
| 2026-08-19 | Melissa Ann King | SVP Product and Technology | F | −1,537 | −$227.91K |
| 2026-08-18 | Craig Conway | Director | A | +2,207 | — |
| 2026-08-18 | Ronald V Waters | Director | A | +2,207 | — |
| 2026-08-18 | Robin Le Pederson | Director | A | +2,207 | — |
| 2026-08-18 | Kenneth B. Robinson | Director | A | +2,207 | — |
| 2026-08-18 | Linda M. Breard | Director | A | +2,207 | — |
| 2026-08-18 | Virginia G Breen | Director | A | +2,207 | — |
| 2026-08-18 | Steven I Sarowitz | Director | MIXED | +1,621 | −$88.56K |
| 2026-08-18 | Steven R Beauchamp | Executive Chairman | MIXED | +8,524 | −$2.23M |
| 2026-08-18 | Melissa Ann King | SVP Product and Technology | A | +34,488 | — |
| 2026-08-18 | Toby J. Williams | President and CEO | MIXED | +149,712 | −$1.78M |
| 2026-08-18 | Nicholas Rost | VP CAO & Treasurer | A | +7,981 | — |
| 2026-08-18 | Andrew Cappotelli | Sr Vice President Operations | A | +31,392 | — |
| 2026-08-18 | Joshua Scutt | SVP Chief Revenue Officer | A | +40,885 | — |
| 2026-08-18 | Ryan Glenn | Chief Financial Officer | A | +64,521 | — |
| 2026-08-17 | Joshua Scutt | SVP Chief Revenue Officer | Sell | −118 | −$17.07K |
| 2026-08-17 | Steven I Sarowitz | Director | Sell | −15,107 | −$2.29M |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| Steven I Sarowitz | Director | 8,269,195 | $1.41B |
| Steven R Beauchamp | Executive Chairman | 1,477,189 | $252.54M |
| Toby J. Williams | President and CEO | 327,309 | $55.96M |
| Ryan Glenn | Chief Financial Officer | 122,563 | $20.95M |
| Joshua Scutt | SVP Chief Revenue Officer | 80,359 | $13.74M |
| Melissa Ann King | SVP Product and Technology | 60,810 | $10.40M |
| Andrew Cappotelli | Sr Vice President Operations | 44,202 | $7.56M |
| Rachit Lohani | Senior Vice President | 37,748 | $6.45M |
| Andres Reiner | Director | 30,593 | $5.23M |
| Nicholas Rost | VP CAO & Treasurer | 13,823 | $2.36M |
| Virginia G Breen | Director | 12,501 | $2.14M |
| Ronald V Waters | Director | 11,640 | $1.99M |
| Robin Le Pederson | Director | 9,199 | $1.57M |
| Kenneth B. Robinson | Director | 6,745 | $1.15M |
| Linda M. Breard | Director | 5,733 | $980.11K |
| Bernard Robinson Kenneth | Director | 5,338 | $912.58K |
| Craig Conway | Director | 2,207 | $377.31K |
| Jeffrey T Diehl | Director | 1,003 | $171.47K |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the PCTY quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.